ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2537

Inactive Systemic Lupus Erythematosus: Cytokines and Soluble Tumor Necrosis Factor Receptors Response To Moderate/Intense Exercise

Luiz A. Perandini1, Diego Sales-de-Oliveira1, Suzana B.V. Mello2, Niels O Camara3, Fernanda R. Lima1, Eduardo F. Borba2, Eloisa Bonfa2, Ana Lucia Sá-Pinto1, Hamilton Roschel4 and Bruno Gualano5, 1University of Sao Paulo, Rheumatology Division, Sao Paulo, Brazil, 2University of Sao Paulo, Rheumatology Division, São Paulo, Brazil, 3Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil, 4Universidade de São Paulo, Faculdade de Educação Física e Esporte, São Paulo, Brazil, 5University of Sao Paulo, School of Physical Education and Sport, Sao Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cytokines, exercise, inflammation and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus-Clinical Aspects III: Biomarkers, Quality of Life and Disease Indicators, Late Complications

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterized by a chronic inflammation associated with worse cardiovascular outcome. Although a few studies have investigated the safety of physical exercise in this disease, none of them have assessed the underlying cytokine response, an important marker of inflammation. Therefore, the aim of this study was to evaluate the cytokines (INF-γ, IL-6, IL-10, TNF-α) and soluble TNF receptors (sTNFR1 and sTNFR2) response to either a moderate or an intense acute exercise session in inactive SLE patients.

Methods:

Twelve patients with SLE [age: 35.3 ± 5.7 yrs; body mass index (BMI): 25.6±3.4 kg/m2; SLEDAI: 1.4±1.0] and 10 healthy age- and BMI-matched controls (age: 30.6±5.2 yrs, P=0.12; BMI: 24.1±2.3 kg/m2, P=1.00) performed 30min of moderate (~50% of VO2max) and intense (~70% of VO2max) exercises in a treadmill, on separate occasions. Serum cytokines (INF-γ, IL-10, IL-6, TNF-α) and sTNFRs were assessed at baseline, immediately after exercise, every 30 min during three hours of recovery, and 24h after the end of exercise. Serum cytokines and sTNFRs were evaluated by the multiplex technique.

Results:

At baseline, SLE had higher levels of TNF-α (P=0.001) and sTNFR2 (P=0.001) when compared with controls, whereas all other cytokines and sTNFR1 levels were comparable between groups (P>0.05). After the moderate exercise session, INF-γ, IL-10, IL-6, TNF-α, sTNFR1 and sTNFR2 levels remained stable in SLE when compared with baseline in all time points (P>0.05). Likewise, both the sTNFR2 and cytokines levels remained unchanged in healthy controls (P>0.05), except for the sTNFR1 levels, which showed a decrease at the 90th (P=0.038), 120th (P=0.028), 150th (P=0.005) and 180th (P=0.037) minute of recovery, returning to baseline levels 24h after the moderate exercise (P=0.093). After the intense exercise, only the sTNFR1 was altered in SLE patients, showing a decrease at the 150th (P=0.041) and 180th (P=0.034) minute of recovery, returning to baseline levels at the 24h time point. The sTNFR2 and all other cytokines remained unchanged (P>0.05). In healthy controls, IL-10, TNF-α, sTNFR1 and sTNFR2 did not change in response to the intense exercise session. Conversely, INF-γ decreased (P=0.05) and IL-6 increased at the end of exercise (P=0.028), with no differences observed at the post-24h time point (P>0.05).

Conclusion:

This study demonstrates that both moderate and intense acute exercise sessions results in mild and transient changes in cytokine levels in SLE, providing novel evidence that exercise does not trigger inflammation in this disease. This finding supports the safety and recommendation of physical exercise for these patients.


Disclosure:

L. A. Perandini,

FAPESP 2011/24093-2,

2;

D. Sales-de-Oliveira,
None;

S. B. V. Mello,

FAPESP 2011/24093-2,

2;

N. O. Camara,
None;

F. R. Lima,

FAPESP 2011/24093-2,

2;

E. F. Borba,

FAPESP 2011/24093-2,

2;

E. Bonfa,

FAPESP 2011/24093-2,

2;

A. L. Sá-Pinto,

FAPESP 2011/24093-2,

2;

H. Roschel,

FAPESP 2011/24093-2,

2;

B. Gualano,

FAPESP 2011/24093-2,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inactive-systemic-lupus-erythematosus-cytokines-and-soluble-tumor-necrosis-factor-receptors-response-to-moderateintense-exercise/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology